Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies

Yongchao Wang,Jinjin Wang,Dandan Zhu,Yufei Wang,Guangchao Qing,Yuxuan Zhang,Xiaoxuan Liu,Xing-Jie Liang
DOI: https://doi.org/10.1016/j.apsb.2021.03.007
IF: 14.903
2021-04-01
Acta Pharmaceutica Sinica B
Abstract:<p>Current advances of immunotherapy have greatly changed the way of cancer treatment. At the same time, a great number of nanoparticle-based cancer immunotherapies (NBCIs) have also been explored to elicit potent immune responses against tumors. However, few NBCIs are nearly in the clinical trial which is mainly ascribed to a lack understanding of <em>in vivo</em> fate of nanoparticles (NPs) for cancer immunotherapy. NPs for cancer immunotherapy mainly target the immune organs or immune cells to enable efficient antitumor immune responses. The physicochemical properties of NPs including size, shape, elasticity and surface properties directly affect their interaction with immune systems as well as their <em>in vivo</em> fate and therapeutic effect. Hence, systematic analysis of the physicochemical properties and their effect on <em>in vivo</em> fate is urgently needed. In this review, we first recapitulate the fundamentals for the <em>in vivo</em> fate of NBCIs including physio-anatomical features of lymphatic system and strategies to modulate immune responses. Moreover, we highlight the effect of physicochemical properties on their <em>in vivo</em> fate including lymph nodes (LNs) drainage, cellular uptake and intracellular transfer. Challenges and opportunities for rational design of NPs for cancer immunotherapy are also discussed in detail.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?